Search details
1.
Lenalidomide maintenance following high-dose therapy and autologous haematopoietic stem cell transplantation in chemo-resistant or high-risk non-Hodgkin lymphoma: A phase I/II study.
Br J Haematol
; 202(1): 116-121, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37096954
2.
Phase 1 trial of carfilzomib in relapsed/refractory peripheral T-cell lymphoma.
Ann Hematol
; 101(2): 335-340, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-34668982
3.
Emergency response to radiological and nuclear accidents and incidents.
Br J Haematol
; 192(6): 968-972, 2021 03.
Article
in English
| MEDLINE | ID: mdl-31388987
4.
The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions.
Oncologist
; 26(8): e1418-e1426, 2021 08.
Article
in English
| MEDLINE | ID: mdl-33586299
5.
Role of molecularly-cloned hematopoietic growth factors after acute high-dose radiation exposures.
J Radiol Prot
; 41(4)2021 Nov 10.
Article
in English
| MEDLINE | ID: mdl-34134098
6.
Mantle-Cell Lymphoma. Reply.
N Engl J Med
; 387(11): 1050, 2022 09 15.
Article
in English
| MEDLINE | ID: mdl-36103423
7.
Mantle-Cell Lymphoma.
N Engl J Med
; 386(26): 2495-2506, 2022 06 30.
Article
in English
| MEDLINE | ID: mdl-35767440
8.
A Better Treatment for Advanced-Stage Hodgkin's Lymphoma?
N Engl J Med
; 387(4): 370-372, 2022 07 28.
Article
in English
| MEDLINE | ID: mdl-35830618
9.
Snake Envenomation.
N Engl J Med
; 386(1): 68-78, 2022 01 06.
Article
in English
| MEDLINE | ID: mdl-34986287
10.
Snake Envenomation. Reply.
N Engl J Med
; 386(11): 1100, 2022 Mar 17.
Article
in English
| MEDLINE | ID: mdl-35294829
11.
Phase I/II study of dasatinib and exploratory genomic analysis in relapsed or refractory non-Hodgkin lymphoma.
Br J Haematol
; 184(5): 744-752, 2019 03.
Article
in English
| MEDLINE | ID: mdl-30520026
12.
Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada.
Oncologist
; 24(4): 537-548, 2019 04.
Article
in English
| MEDLINE | ID: mdl-30842244
13.
Effects of center type and socioeconomic factors on early mortality and overall survival of diffuse large B-cell lymphoma.
Future Oncol
; 15(18): 2113-2124, 2019 Jun.
Article
in English
| MEDLINE | ID: mdl-31144521
14.
Non-Hodgkin lymphoma.
Lancet
; 390(10091): 298-310, 2017 07 15.
Article
in English
| MEDLINE | ID: mdl-28153383
15.
Is watch and wait still acceptable for patients with low-grade follicular lymphoma?
Blood
; 127(23): 2804-8, 2016 06 09.
Article
in English
| MEDLINE | ID: mdl-26994147
16.
Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma.
Blood
; 125(7): 1137-45, 2015 Feb 12.
Article
in English
| MEDLINE | ID: mdl-25498913
17.
Myeloid Growth Factors, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 15(12): 1520-1541, 2017 12.
Article
in English
| MEDLINE | ID: mdl-29223990
18.
The aggressive peripheral T-cell lymphomas: 2017.
Am J Hematol
; 92(7): 706-715, 2017 Jul.
Article
in English
| MEDLINE | ID: mdl-28516671
19.
Leukemic transformation in patients with myeloproliferative neoplasms: a population-based retrospective study.
Future Oncol
; 13(14): 1239-1246, 2017 Jun.
Article
in English
| MEDLINE | ID: mdl-28589759
20.
Generic oncology drugs: are they all safe?
Lancet Oncol
; 17(11): e493-e501, 2016 Nov.
Article
in English
| MEDLINE | ID: mdl-27819247